MeNow

About

Funding history · 3 rounds · — total

Headcount over time

Offices

Q&A

What is MeNow's primary focus?

MeNow is an AI-driven discovery company focused on developing novel natural bioactive compounds for food, cosmetics, and health applications.

What technology does MeNow utilize in its discovery process?

MeNow integrates advanced probabilistic AI, systems biology, and molecular science to identify and validate new bioactives.

What specific biological pathways has MeNow focused on for intellectual property generation?

MeNow has generated proprietary intellectual property around key pathways such as SIRT1 activation, heparanase modulation, and GLP-1–associated mechanisms.

What are the application areas for MeNow's discoveries?

MeNow's discoveries have applications across metabolic health, inflammation, tissue function, and healthspan support, translating into consumer and health solutions.

When was MeNow founded?

MeNow was founded in July 2022.

How many employees does MeNow currently have?

MeNow has 38 employees, falling within the 11-50 employee bucket.

What is MeNow's current funding stage?

MeNow is currently in the Pre-Funding stage.

Where is MeNow headquartered?

MeNow is headquartered in Ramat Gan, Center District, Israel.

Team · 18

Hilla Ben-Hamo

Founder · CEO & Co-Founder

Coralie Ebert

Founder · CTO & Co-Founder

Dr. Bat-Chen Tamim

Scientific Operation Manager

Osher Hason

Product Manager

Netta Habani

Project Manager

Yotam Ronen

Database Manager

Dr. Eldad Assa

Team Lead

Dr. Shani Zeev

Chemoinformatician

Victoria Strahova

executives

Daniel Ben-Zvi

Data Scientist

Yam Tamim

Backend Developer

Alexander Baytman

Frontend Developer

Dr. Sol Adam

Algorithm Developer

Limor Rotem

Product Designer

Ophir Kantor

executives

Shahar Medina

Biological Research analyst

Ophir Nadler

Business Operations Manager

Adaya Ashkenazi

Fullstack Developer

Sectors & technology

Tags